BRESATEC LTD has a total of 12 patent applications. Its first patent ever was published in 1988. It filed its patents most often in Australia, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets biotechnology, agriculture and pharmaceuticals are DNX BIOTHERAPEUTICS INC, STERRENBELD BIOTECHNOLOGIE NORTH AMERICA INC and DNX CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 2 | |
#3 | Canada | 1 | |
#4 | Mexico | 1 | |
#5 | New Zealand | 1 | |
#6 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Agriculture | |
#3 | Pharmaceuticals | |
#4 | Basic materials chemistry |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Animal care | |
#3 | Microorganisms | |
#4 | Medical preparations | |
#5 | Preservation of human bodies |
# | Name | Total Patents |
---|---|---|
#1 | Pearse Martin J | 4 |
#2 | Crawford Robert J | 4 |
#3 | Apice Anthony J F D | 4 |
#4 | Robbins Allan J | 3 |
#5 | Rathjen Peter D | 3 |
#6 | Nagashima Hiroshi | 2 |
#7 | Nottle Mark Brenton | 2 |
#8 | Kashiwazaki Naomi | 2 |
#9 | Wells Julian Richard Este | 2 |
#10 | Seamark Robert Frederick | 2 |
Publication | Filing date | Title |
---|---|---|
AUPN733295A0 | Site-specific recombination of DNA eukaryotic and prokaryotic cells | |
AUPN166295A0 | Xenotransplantation | |
AUPN088695A0 | Radiolabelled formulation | |
WO9520661A1 | Materials and methods for management of hyperacute rejection in human xenotransplantation | |
MX9603037A | Materials and methods for management of hyperacute rejection in human xenotransplantation. | |
US5849991A | Mice homozygous for an inactivated α 1,3-galactosyl transferase gene | |
AU7453294A | Cryopreservation of porcine embryos | |
WO9505075A1 | Cryopreservation of porcine embryos | |
AUPM323394A0 | Insertion of exogenous dna into eukaryotic genomes and generation of transgenic animals | |
AU1700488A | Method of creating new breeds of mammals | |
NZ224241A | Method of producing new animal breeds using plasmid expression vectors; plasmid expression vectors |